BlackRock Health Sciences Opportunities Portfolio Institutional Shares SHSSX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 69.58  /  −1.68 %
  • Total Assets 6.2B
  • Adj. Expense Ratio
    0.860%
  • Expense Ratio 0.860%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 2M
  • Status Open
  • TTM Yield 0.35%
  • Turnover 49%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0

Morningstar’s Analysis SHSSX

Will SHSSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Instl holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSSX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 53.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

11.92 760M
Healthcare

Johnson & Johnson

8.03 512M
Healthcare

Merck & Co Inc

5.56 355M
Healthcare

AbbVie Inc

5.07 323M
Healthcare

Thermo Fisher Scientific Inc

4.41 281M
Healthcare

UnitedHealth Group Inc

4.33 276M
Healthcare

Gilead Sciences Inc

4.09 261M
Healthcare

Amgen Inc

3.98 254M
Healthcare

Vertex Pharmaceuticals Inc

3.33 212M
Healthcare

Abbott Laboratories

2.61 167M
Healthcare

Sponsor Center